Database of All Patients With Microbiologically Proven Mycobacteria Tuberculosis Infection
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01601275|
Recruitment Status : Recruiting
First Posted : May 17, 2012
Last Update Posted : November 8, 2017
|Condition or disease|
Tuberculosis currently infects one third of the world's population and is responsible for killing approximately 2 million individuals annually. This is a major public health concern worldwide, and there has been a huge impetus to implement strategies for better tuberculosis control.
The investigators have established a system to track all patients with microbiologically proven tuberculosis treated at Singapore General Hospital, with vigilant recording and reporting systems, from the first instance when patients were diagnosed to the time they have completed anti-tuberculosis chemotherapy. The investigators endeavour to use this system to improve patient care by adopting patient-supportive approaches that lead to high compliance rates and best possible outcomes of treatment.
|Study Type :||Observational|
|Estimated Enrollment :||4000 participants|
|Official Title:||Prospective Database of All Patients With Microbiologically Proven Mycobacteria Tuberculosis Infection Treated at Singapore General Hospital|
|Study Start Date :||May 2012|
|Estimated Primary Completion Date :||May 2022|
|Estimated Study Completion Date :||May 2022|
- Final outcomes of patients who have been diagnosed with microbiologically proven mycobacteria tuberculosis infection at Singapore General Hospital [ Time Frame: From diagnosis to final outcome ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01601275
|Contact: Su Ying Low, BMBCh||+65 email@example.com|
|Singapore General Hospital||Recruiting|
|Singapore, Singapore, 169608|
|Principal Investigator:||Su Ying Low, BMBCh||Singapore General Hospital|